Evidence map›Paper›PMID 28348151›Full record

ArticleAntimicrobial agents and chemotherapy2017

Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.

Katherine M Shea, Athena L V Hobbs, Theresa C Jaso, Jack D Bissett, Christopher M Cruz, Elizabeth T Douglass, Kevin W Garey

Abstract readMulticenter Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trends and Impact ofGastroenterology research · 2026
    Article
  2. Article
  3. Effect of Pefloxacin onAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  14. Article
  15. Article
  16. Hospital Infection Control:Clinics in colon and rectal surgery · 2020
    Review
  17. Article
  18. Comparison of Fluoroquinolone Versus Non-Fluoroquinolone Therapy for Inpatient Treatment of Chronic Obstructive Pulmonary Disease Exacerbations.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katherine M SheaCardinal Health, Innovative Delivery Solutions, Houston, Texas, USA kate.shea@cardinalhealth.com.
Athena L V HobbsBaptist Memorial Hospital, Memphis, Tennessee, USA.
Theresa C JasoSeton Healthcare Family, Austin, Texas, USA.
Jack D BissettAustin Infectious Diseases Consultants, Austin, Texas, USA.
Christopher M CruzUniversity Medical Center Brackenridge, Austin, Texas, USA.
Elizabeth T DouglassThe University of Texas at Austin Dell Medical School, Austin, Texas, USA.
Kevin W GareyUniversity of Houston College of Pharmacy, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluoroquinolones are one of the most commonly prescribed antibiotic classes in the United States despite their association with adverse consequences, including

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipClostridioides difficileClostridium InfectionsDrug Resistance, BacterialFluoroquinolonesHumansInfection ControlMoxifloxacinRespiratory Tract InfectionsUnited StatesAnti-Bacterial AgentsFluoroquinolonesMoxifloxacinantimicrobial stewardshipClostridium difficilefluoroquinolones

Identifiers

PMID28348151
PMCPMC5444144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.